10.08.14
Texas A&M University System and XOMA Corp. have entered a non-exclusive license agreement for XOMA's manufacturing technology for the design of a new facility. The technology relates to a flexible arrangement of mobile clean rooms (MCRs) within the manufacturing facility with each MCR providing a portable, self-contained environment that allows for drug development. The A&M System will use MCRs for certain government programs at The National Center for Therapeutics Manufacturing (NCTM) facility located at Texas A&M University in College Station, TX. Additional details were not disclosed.
"This license validates our flexible manufacturing design as it will be in practice initially at a well-known educational facility," said Patrick J. Scannon, MD, Ph.D., founder and chief scientific officer of XOMA. "Mobile clean rooms have the potential to transform the industry because of their 'plug and play' design, which offers benefits of easy scalability and reduced clean-out and set-up times. In addition, they offer the potential to respond to possible threats in locales where pharmaceutical or biologic manufacturing facilities are otherwise not available."
"This license validates our flexible manufacturing design as it will be in practice initially at a well-known educational facility," said Patrick J. Scannon, MD, Ph.D., founder and chief scientific officer of XOMA. "Mobile clean rooms have the potential to transform the industry because of their 'plug and play' design, which offers benefits of easy scalability and reduced clean-out and set-up times. In addition, they offer the potential to respond to possible threats in locales where pharmaceutical or biologic manufacturing facilities are otherwise not available."